Guide
Noom Microdose GLP-1: what it is, what it costs, and what to ask
Contents
- 01What Noom Microdose is
- 02How it works, according to Noom
- 03What it costs
- 04Who's eligible
- 05What Noom says about results
- 06Compounded, not FDA-approved
- 07What doctors say about microdosing
- 08Questions to ask before you sign up
- 09Use cases: what to do in common situations
- 10Get daily support for your habits
What Noom Microdose is
Noom describes its Microdose GLP-1 Rx Program as "GLP-1 treatment paired with Noom behavior change Program." On its microdose page, Noom says the program offers "Microdose Compounded Semaglutide and Tirzepatide" and provides "a smaller dose compared to our standard GLP‑1 plan."
According to Noom, the program:
- is a "Low-dose GLP-1 designed to reduce observable side effects"
- comes with "the same comprehensive Noom program and clinical care and support" as its other Med programs
- includes a clinician evaluation, medication shipped to your door, ongoing prescription management, 1:1 coaching, a psychology-based curriculum, in-app food logging and weight tracking
Noom also lists a Plus version with tirzepatide and a separate Proactive Health Microdose program that adds at-home biomarker testing.
How it works, according to Noom
Noom lays out four steps:
- Intake survey. You share your health history and weight-loss goals.
- Clinician review. A clinician evaluates your answers online and prescribes "if clinically appropriate."
- Medication and plan. If you're eligible, medication is shipped to you along with a customized plan.
- Ongoing care. Noom says you get continuous monitoring and dose adjustments, with "unlimited access to your clinician and medication refills, where clinically appropriate."
Noom says "Not all customers will qualify for prescription."
What it costs
Here's what Noom's own pages listed when we opened them on October 28, 2026. Prices change, so check at checkout.
Noom page | What it listed |
|---|---|
Microdose GLP-1 Rx Program page | $79 to get started, then $179/month; includes medication (if prescribed), ongoing care and full program access |
Pricing page | $79 to get started; $179/month after the first 4-week supply (billed quarterly) |
Noom cost blog | Microdose (semaglutide): $79 for the first 4-week supply, then $537 every 12 weeks ($179 per month). Microdose Plus (tirzepatide): $99, then $597 every 12 weeks ($199 per month). Proactive Health Microdose: $149 per month for a 4-month subscription |
Noom's pages don't all agree. The program page's FAQ says it "starts at $49 for your first 4-week supply," and Noom's December 2025 microdosing blog post says $199 per month after the first 3 weeks. A footnote on Noom's microdose page says "New pricing for new accounts only effective as of July 27, 2026." If you're comparing, ask Noom to confirm your total for the first 12 weeks in writing.
Noom says the program doesn't require insurance and that you can generally use FSA or HSA funds.
Who's eligible
Noom says "You may be eligible if you have a BMI of 25 or higher," and that a licensed clinician reviews your health history, current medications and goals during a short online assessment. Noom's program page says the program is available in all U.S. states except Alabama, Louisiana and Mississippi.
What Noom says about results
Noom's pages make several weight-loss claims, each with a footnote:
- The program and pricing pages say "Lose up-to 11 lbs in 60 days," based on self-reported data from 7,377 Noom users. The footnote says average expected weight loss for those who followed the titration protocol was 7.6 lbs.
- Noom's microdose page says "Lose up to 17 pounds in 60 days." A footnote on the program page explains that figure is the top 25th percentile of self-reported data from 1,185 Noom Med users prescribed compounded GLP-1s, with an average of 13 pounds.
These are Noom's own figures from self-reported app data, not results from an independent clinical trial. Noom's pages also say "Individual results vary."
Compounded, not FDA-approved
The medicines in Noom's microdose plans are compounded. Noom's own footnote says its compounded semaglutide "is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality."
The FDA says compounded drugs "are not FDA approved," which means the agency doesn't review them for safety, effectiveness or quality before they're marketed. It says compounded drugs should only be used when a patient's medical needs can't be met by an FDA-approved drug. The FDA also lists telehealth red flags, such as a company claiming a compounded drug is the same as an FDA-approved one, prices that seem too good to be true, or no licensed doctor available to answer questions after you get your medicine.
What doctors say about microdosing
In a July 2026 Cleveland Clinic article, obesity medicine subspecialist W. Scott Butsch, MD, explains why he doesn't recommend it:
- There aren't official or standard guidelines for microdosing GLP-1s, and the American Diabetes Association doesn't endorse it.
- There isn't enough research on the effectiveness or safety of microdosing compounded GLP-1s.
- Compounded versions aren't all concentrated the same way, so measuring small doses can lead to taking more than intended.
Dr. Butsch also says doctors routinely adjust GLP-1 doses for effectiveness, tolerability or side effects: "that's not microdosing — that's just the art of practicing medicine." If you have questions about your dose, side effects or cost, take them to your prescriber, and never change your dose on your own.
Questions to ask before you sign up
- Which medicine would I get, and is it compounded or FDA-approved?
- What will I pay for the first 12 weeks, and what does it renew at?
- Who is my clinician, and how do I reach them after the medicine arrives?
- What happens if I have side effects or the plan isn't working?
- Which pharmacy fills the prescription, and how is the medicine shipped and stored?
- How do I cancel, and is anything refundable?
The habits side matters too. Noom's microdosing blog post says microdosing GLP-1s "works best when paired with healthy habits around eating, movement, and mindset." For more on the app side, see why Noom isn't working for some people and what Noom coaches' credentials mean.
If your main need is daily support with those habits, a health companion app can help too. Olive checks in with you every day, looks at what you eat, and helps you build small habits that hold. It doesn't diagnose or treat anything, so questions about a prescription stay with your prescriber.
Use cases: what to do in common situations
- "I want a GLP-1 but the full-dose price scares me." Compare the 12-week total in writing, and ask whether the medicine is compounded or FDA-approved.
- "I had side effects on a GLP-1 before." Raise that with a clinician, who can adjust treatment. Don't cut your own doses.
- "I'm already on Noom's app." Ask Noom how the Med programs differ from the app you have now before upgrading.
- "I'm comparing programs." Our Noom alternatives hub lays out other options.
This guide is general information, not medical advice. Talk with your clinician about your own situation.
Get daily support for your habits
Whatever program you choose, the day-to-day habits are yours. Olive checks in with you every day and helps you build small habits that hold.
Reader questions
- What is Noom Microdose?
- It's Noom's Microdose GLP-1 Rx Program, a telehealth plan that pairs lower-dose compounded semaglutide or tirzepatide, if prescribed, with Noom's coaching, lessons and tracking tools. Noom says it offers a smaller dose than its standard GLP-1 plan.
- How much does Noom Microdose cost?
- On October 28, 2026, Noom's program and pricing pages listed $79 to get started, then $179 a month, with medication included. Other Noom pages listed different figures, including $49 to start and $199 a month, so confirm your total before you sign up.
- Is Noom Microdose FDA-approved?
- No. Noom says its compounded semaglutide has not been reviewed by the FDA for safety, efficacy or quality. The FDA says compounded drugs are not FDA approved and should only be used when an FDA-approved drug can't meet a patient's needs.
- Who qualifies for Noom Microdose?
- Noom says you may be eligible with a BMI of 25 or higher, after a licensed clinician reviews your health history online. Noom lists the program as unavailable in Alabama, Louisiana and Mississippi.
- Is microdosing a GLP-1 safe?
- There isn't enough research to say. A Cleveland Clinic obesity medicine specialist says there are no standard microdosing guidelines and not enough data on microdosing compounded GLP-1s. Talk with a clinician, and don't change your dose on your own.
- Does Noom Microdose require insurance?
- No. Noom says you can enroll and pay out of pocket, and that you can generally use FSA or HSA funds.
Sources
- S01Noom. "Noom Microdose GLP-1 Rx Program" (program page; prices as listed), Noom (checked 28 Oct 2026)
- S02Noom. "Microdose: More ways to get started" (microdose page), Noom (checked 28 Oct 2026)
- S03Noom. "Noom Weight-loss Medication Programs & Pricing.", Noom (checked 28 Oct 2026)
- S04Noom. "Noom Program Cost in 2026" (blog), Noom (checked 28 Oct 2026)
- S05Noom. "Microdosing GLP-1 for weight loss: Benefits, schedule, side effects, & cost" (blog, December 17, 2025), Noom (checked 28 Oct 2026)
- S06U.S. Food and Drug Administration. "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss" (content current as of October 1, 2026), U.S (checked 28 Oct 2026)
- S07Cleveland Clinic Health Essentials. "Should You Microdose GLP-1 Medications?" (July 31, 2026), Cleveland Clinic Health Essentials (checked 28 Oct 2026)
- S08Olive homepage (companion description: "checks in with you every day, looks at what you eat"; "doesn't diagnose or treat anything"), Olive (checked 28 Oct 2026)